» Articles » PMID: 15548491

Neurosyphilis in the Modern Era

Overview
Date 2004 Nov 19
PMID 15548491
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To review the nature of the presentation of neurosyphilis, the value of diagnostic tests, and the classification of the disease.

Methods: A retrospective review was carried out of the records of patients who had been identified as possible cases of neurosyphilis by a positive FTA-abs test in the CSF. The review extended over 10 years at a single hospital which served a population of mixed ancestry in a defined catchment area in the Western Cape province of South Africa. Patients were placed in predefined diagnostic categories, and clinical, radiological, and laboratory features were assessed.

Results: 161 patients met diagnostic criteria for neurosyphilis: 82 presented with combinations of delirium and dementia and other neuropsychiatric conditions, and the remainder had typical presentations such as stroke (24), spinal cord disease (15), and seizures (14). The average age of presentation ranged from 35.9 to 42.6 years in the different categories of neurosyphilis. Of those followed up, 77% had residual deficits from their initial illness. Cerebrospinal fluid (CSF) VDRL was positive in 73% of cases.

Conclusions: The diagnosis of neurosyphilis can be made with reasonable certainty if there is an appropriate neuropsychiatric syndrome associated with a positive CSF VDRL. If the VDRL is negative, a positive FTA-abs in an appropriate clinical setting, associated with raised CSF cell count, protein, or IgG index, is a useful method of identifying neurosyphilis. Tabes dorsalis has become uncommon, but this is likely to be the only manifestation of neurosyphilis that has been altered during the antibiotic era.

Citing Articles

A historic case of relapsing-remitting Alzheimer's disease in an adolescent attributed to scarlet fever.

Lathe R, Balin B J Alzheimers Dis Rep. 2025; 9:25424823241298530.

PMID: 40034507 PMC: 11864263. DOI: 10.1177/25424823241298530.


Southern African HIV Clinicians Society Guideline for the clinical management of syphilis.

Peters R, Nel J, Sadiq E, Kufa T, Smit D, Sorour G South Afr J HIV Med. 2024; 25(1):1577.

PMID: 38725703 PMC: 11079416. DOI: 10.4102/sajhivmed.v25i1.1577.


Cerebral syphilitic gumma misdiagnosed as brain abscess: A case report.

Mu L, Cheng L, Ye J, Zhao M, Wang J World J Clin Cases. 2024; 12(3):650-656.

PMID: 38322467 PMC: 10841954. DOI: 10.12998/wjcc.v12.i3.650.


Neurosyphilis-Induced Folie À Deux: A Case of Prolonged Psychosis.

Alves M, Pinheiro Ramos C, Duraes D, Mendes S, Gamito A Cureus. 2023; 15(10):e46375.

PMID: 37920639 PMC: 10619995. DOI: 10.7759/cureus.46375.


Neurosyphilis with ocular involvement and normal magnetic resonance imaging results affirmed by metagenomic next-generation sequencing.

Zhou X, Peng S, Song T, Tie D, Tao X, Jiang L Front Cell Infect Microbiol. 2022; 12:985373.

PMID: 36530424 PMC: 9756949. DOI: 10.3389/fcimb.2022.985373.


References
1.
DEACON W, LUCAS J, PRICE E . Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis. JAMA. 1966; 198(6):624-8. View

2.
Tichonova L, Borisenko K, Ward H, Meheus A, Gromyko A, Renton A . Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet. 1997; 350(9072):210-3. DOI: 10.1016/S0140-6736(97)01382-2. View

3.
Hooshmand H, Escobar M, Kopf S . Neurosyphilis. A study of 241 patients. JAMA. 1972; 219(6):726-9. DOI: 10.1001/jama.219.6.726. View

4.
Molteno A . Modified neurosyphilis in the Cape Peninsula. S Afr Med J. 1978; 53(1):10-4. View

5.
Leclerc G, Giroux M, Birry A, Kasatiya S . Study of fluorescent treponemal antibody test on cerebrospinal fluid using monospecific anti-immunoglobulin conjugates IgG, IgM, and IgA. Br J Vener Dis. 1978; 54(5):303-8. PMC: 1045528. View